Global miRNA dosage control of embryonic germ layer specification

MicroRNAs (miRNAs) have essential functions during embryonic development, and their dysregulation causes cancer(1,2). Altered global miRNA abundance is found in different tissues and tumours, which implies that precise control of miRNA dosage is important(1,3,4), but the underlying mechanism(s) of this control remain unknown. The protein complex Microprocessor, which comprises one DROSHA and two DGCR8 proteins, is essential for miRNA biogenesis(5-7). Here we identify a developmentally regulated miRNA dosage control mechanism that involves alternative transcription initiation (ATI) of DGCR8. ATI occurs downstream of a stem-loop in DGCR8 mRNA to bypass an autoregulatory feedback loop during mouse embryonic stem (mES) cell differentiation. Deletion ofthe stem-loop causes imbalanced DGCR8:DROSHA protein stoichiometry that drives irreversible Microprocessor aggregation, reduced primary miRNA processing, decreased mature miRNA abundance, and widespread de-repression of lipid metabolic mRNA targets. Although global miRNA dosage control is not essential for mES cells to exit from pluripotency, its dysregulation alters lipid metabolic pathways and interferes with embryonic development by disrupting germ layer specification in vitro and in vivo. This miRNA dosage control mechanism is conserved in humans. Our results identify a promoter switch that balances Microprocessor autoregulation and aggregation to precisely control global miRNA dosage and govern stem cell fate decisions during early embryonic development.

Automated summary

microRNAs play essential roles in embryonic development, with dysregulation potentially leading to cancer. Alterations in global miRNA abundance can affect lipid metabolic pathways. Imbalance in the Microprocessor protein complex can reduce miRNA processing and interfere with embryonic development.